Allergan rejects Valeant and Ackman's raised takeover offer: Reuters
The battle for botox maker Allergan Inc heated up as the company officially rejected a sweetened US$53 billion takeover offer from Valeant Pharmaceuticals International and activist investor William Ackman, Reuters reported. Since Canadian drugmaker Valeant and Pershing Square Capital Management made a joint bid for the company on April 22, Allergan has stood firm against entreaties to sit down at the table and negotiate a deal.
11 June 2014•2 mins read
